Case number 1:22-cv-00971
Covis Pharma GmbH et al v. Eugia Pharma Specialties Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 19, 2023 | 20 | Final Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,304,962. (apk) (Entered: 04/19/2023) (1) |
| Apr 17, 2023 | 18 | Letter to The Honorable Kent A. Jordan from Geoffrey Grivner regarding regarding FDA final decision. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 21-cv-0003 (Proposed) Order of Dismissal, # 4 22-cv-0971 (Proposed) Order of Dismissal)(Grivner, Geoffrey) (Entered: 04/17/2023) (Main Document) (2) |
| Apr 17, 2023 | 19 | ORDER DISMISSING CASE (copy to pltf.) (CASE CLOSED). Signed by Judge Kent A. Jordan on 04/17/2023. (apk) (Entered: 04/17/2023) (2) |
| Apr 17, 2023 | 18 | Letter to The Honorable Kent A. Jordan from Geoffrey Grivner regarding regarding FDA final decision. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 21-cv-0003 (Proposed) Order of Dismissal, # 4 22-cv-0971 (Proposed) Order of Dismissal)(Grivner, Geoffrey) (Entered: 04/17/2023) (Exhibit 1) (27) |
| Apr 17, 2023 | 18 | Letter to The Honorable Kent A. Jordan from Geoffrey Grivner regarding regarding FDA final decision. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 21-cv-0003 (Proposed) Order of Dismissal, # 4 22-cv-0971 (Proposed) Order of Dismissal)(Grivner, Geoffrey) (Entered: 04/17/2023) (Exhibit 2) (2) |
| Apr 17, 2023 | 18 | Letter to The Honorable Kent A. Jordan from Geoffrey Grivner regarding regarding FDA final decision. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 21-cv-0003 (Proposed) Order of Dismissal, # 4 22-cv-0971 (Proposed) Order of Dismissal)(Grivner, Geoffrey) (Entered: 04/17/2023) (21-cv-0003 (Proposed) Order of Dismissal) (2) |
| Apr 17, 2023 | 18 | Letter to The Honorable Kent A. Jordan from Geoffrey Grivner regarding regarding FDA final decision. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 21-cv-0003 (Proposed) Order of Dismissal, # 4 22-cv-0971 (Proposed) Order of Dismissal)(Grivner, Geoffrey) (Entered: 04/17/2023) (22-cv-0971 (Proposed) Order of Dismissal) (2) |
| Dec 13, 2022 | 16 | ORDER, Having considered the Parties' Joint Motion to Stay the Litigation, IT IS HEREBY ORDERED this 13th day of December, 2022, that the motion is GRANTED and that this proceeding is hereby stayed. Defendants shall produce to counsel for Plaintiffs correspondence between Defendants and the FDA concerning Defendants' ANDA within 14 days of sending or receiving such correspondence. The Parties shall file a joint status report on or before the earliest of (a) 120 days from this Order; (b) 14 days from the date the FDA takes any action upon the Proposal to Withdraw Marketing Approval of Plaintiffs' NDA; or (c) 14 days from the date the FDA takes any action on Defendants' ANDA or Defendants withdraw their ANDA. Signed by Judge Kent A. Jordan on 12/13/2022. (apk) (Entered: 12/13/2022) (2) |
| Dec 13, 2022 | 17 | ORDER, The case is ADMINISTRATIVELY CLOSED. The parties shall promptly notify the Court when the proceedings before the FDA have been resolved so that this case may be reopened and other appropriate action may be taken. Signed by Judge Kent A. Jordan on 12/13/2022. (apk) (Entered: 12/13/2022) (1) |
| Dec 9, 2022 | 14 | [SEALED] STATUS REPORT Plaintiffs' Status Report by AMAG Pharma USA, Inc., AMAG Pharmaceuticals, Inc., Covis Pharma GmbH. (Grivner, Geoffrey) (Entered: 12/09/2022) (0) |
| Dec 9, 2022 | 15 | STATUS REPORT Defendants' Status Report by AuroMedics Pharma LLC, Aurobindo Pharma U.S.A., Inc., Aurobindo Pharma, Ltd., Eugia Pharma Specialties Ltd.. (Myer, R.) (Entered: 12/09/2022) (2) |
| Nov 11, 2022 | 13 | [SEALED] Joint MOTION to Stay - filed by AMAG Pharma USA, Inc., AMAG Pharmaceuticals, Inc., Covis Pharma GmbH. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Text of Proposed Order)(Grivner, Geoffrey) (Entered: 11/11/2022) (0) |
| Oct 21, 2022 | 12 | Order Setting Telephonic Scheduling Conference: A Scheduling Conference is set for 11/17/2022 at 02:00 PM before Judge Kent A. Jordan. (See Order for further details) Signed by Judge Kent A. Jordan on 10/21/2022. (Attachments: # 1 Scheduling Order, # 2 Proposed Final Pretrial Order) (smg) (Entered: 10/21/2022) (Main Document) (2) |
| Oct 21, 2022 | 12 | Order Setting Telephonic Scheduling Conference: A Scheduling Conference is set for 11/17/2022 at 02:00 PM before Judge Kent A. Jordan. (See Order for further details) Signed by Judge Kent A. Jordan on 10/21/2022. (Attachments: # 1 Scheduling Order, # 2 Proposed Final Pretrial Order) (smg) (Entered: 10/21/2022) (Scheduling Order) (12) |
| Oct 21, 2022 | 12 | Order Setting Telephonic Scheduling Conference: A Scheduling Conference is set for 11/17/2022 at 02:00 PM before Judge Kent A. Jordan. (See Order for further details) Signed by Judge Kent A. Jordan on 10/21/2022. (Attachments: # 1 Scheduling Order, # 2 Proposed Final Pretrial Order) (smg) (Entered: 10/21/2022) (Proposed Final Pretrial Order) (4) |
| Oct 3, 2022 | 11 | SO ORDERED, re 10 MOTION for Pro Hac Vice Appearance of Attorney Timothy H. Kratz and Michael P. Hogan filed by Aurobindo Pharma U.S.A., Inc., AuroMedics Pharma LLC, Eugia Pharma Specialties Ltd., Aurobindo Pharma, Ltd. Ordered by Judge Kent A. Jordan on 10/3/2022. (srs) (Entered: 10/03/2022) (0) |
| Sep 26, 2022 | 8 | ANSWER to 1 Complaint, by AuroMedics Pharma LLC, Aurobindo Pharma U.S.A., Inc., Aurobindo Pharma, Ltd., Eugia Pharma Specialties Ltd..(Myer, R.) (Entered: 09/26/2022) (24) |
| Sep 26, 2022 | 9 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aurobindo Pharma Ltd. for AuroMedics Pharma LLC, Aurobindo Pharma U.S.A., Inc., Eugia Pharma Specialties Ltd. filed by AuroMedics Pharma LLC, Aurobindo Pharma U.S.A., Inc., Aurobindo Pharma, Ltd., Eugia Pharma Specialties Ltd.. (Myer, R.) (Entered: 09/26/2022) (2) |
| Sep 26, 2022 | 10 | MOTION for Pro Hac Vice Appearance of Attorney Timothy H. Kratz and Michael P. Hogan - filed by AuroMedics Pharma LLC, Aurobindo Pharma U.S.A., Inc., Aurobindo Pharma, Ltd., Eugia Pharma Specialties Ltd.. (Myer, R.) (Entered: 09/26/2022) (3) |
| Jul 27, 2022 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Kent A. Jordan of the United States Court of Appeals for the Third Circuit. Please include the initials of the Judge (KAJ) after the case number on all documents filed. (rjb) |
| Jul 27, 2022 | 7 | Order (1) Docket Text: ORDER: DESIGNATION OF CIRCUIT JUDGE TO HOLD A DISTRICT COURT WITHIN THE CIRCUIT, designating and assigning the Honorable Kent A. Jordan of the United States Court of Appeals for the Third Circuit. Signed by Judge Michael A Chagares, Chief Judge of the United States Court of Appeals for the Third Circuit on 7/27/2022. (rjb) |
| Jul 25, 2022 | 1 | Main Document (20) Docket Text: COMPLAINT filed against AuroMedics Pharma LLC, Aurobindo Pharma U.S.A., Inc., Aurobindo Pharma, Ltd., Eugia Pharma Specialties Ltd. ( Filing fee $ 402, receipt number ADEDC-3921875.) - filed by Covis Pharma GmbH, AMAG Pharma USA, Inc., AMAG Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(twk) |
| Jul 25, 2022 | 1 | Exhibit A (20) |
| Jul 25, 2022 | 1 | Civil Cover Sheet (2) |
| Jul 25, 2022 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (twk) |
| Jul 25, 2022 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: June 8, 2022. Date of Expiration of Patent: May 2, 2036. Thirty Month Stay Deadline: 5/24/2023. (twk) |
| Jul 25, 2022 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,304,962. (twk) |
| Jul 25, 2022 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Covis Group S.a r.l., Other Affiliate Apollo Management, L.P. for Covis Pharma GmbH; Corporate Parent AMAG Pharmaceuticals, Inc., Other Affiliate Apollo Management, L.P. for AMAG Pharma USA, Inc.; Corporate Parent Covis Holdings US, Inc., Other Affiliate Apollo Management, L.P. for AMAG Pharmaceuticals, Inc. filed by AMAG Pharma USA, Inc., AMAG Pharmaceuticals, Inc., Covis Pharma GmbH. (twk) |
| Jul 25, 2022 | 6 | Summons Issued (2) Docket Text: Summons Issued as to Eugia Pharma Specialties Ltd. on 7/25/2022. (twk) |
| Jul 25, 2022 | 1 | Complaint* (1) |
